Bionano Genomics Statistics
Total Valuation
BNGO has a market cap or net worth of $76.22 million. The enterprise value is $60.92 million.
| Market Cap | 76.22M |
| Enterprise Value | 60.92M |
Important Dates
The last earnings date was Wednesday, May 8, 2024, after market close.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BNGO has 66.86 million shares outstanding. The number of shares has increased by 74.60% in one year.
| Shares Outstanding | 66.86M |
| Shares Change (YoY) | +74.60% |
| Shares Change (QoQ) | +32.30% |
| Owned by Insiders (%) | 0.39% |
| Owned by Institutions (%) | 10.04% |
| Float | 54.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.03 |
| Forward PS | 1.81 |
| PB Ratio | 0.92 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.63 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.46.
| Current Ratio | 1.46 |
| Quick Ratio | 1.05 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -42.91 |
Financial Efficiency
Return on equity (ROE) is -176.90% and return on invested capital (ROIC) is -169.99%.
| Return on Equity (ROE) | -176.90% |
| Return on Assets (ROA) | -109.90% |
| Return on Capital (ROIC) | -169.99% |
| Revenue Per Employee | $108,924 |
| Profits Per Employee | -$659,276 |
| Employee Count | 344 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 1.03 |
Taxes
In the past 12 months, BNGO has paid $18,000 in taxes.
| Income Tax | 18,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.71% in the last 52 weeks. The beta is 2.41, so BNGO's price volatility has been higher than the market average.
| Beta (1Y) | 2.41 |
| 52-Week Price Change | -83.71% |
| 50-Day Moving Average | 0.98 |
| 200-Day Moving Average | 1.80 |
| Relative Strength Index (RSI) | 64.56 |
| Average Volume (30 Days) | 1,430,124 |
Short Selling Information
The latest short interest is 5.15 million, so 7.71% of the outstanding shares have been sold short.
| Short Interest | 5.15M |
| Short Previous Month | 5.36M |
| Short % of Shares Out | 7.71% |
| Short % of Float | 9.45% |
| Short Ratio (days to cover) | 3.29 |
Income Statement
In the last 12 months, BNGO had revenue of $37.47 million and -$226.79 million in losses. Loss per share was -$6.02.
| Revenue | 37.47M |
| Gross Profit | 10.32M |
| Operating Income | -205.08M |
| Pretax Income | -226.77M |
| Net Income | -226.79M |
| EBITDA | -207.91M |
| EBIT | -221.61M |
| Loss Per Share | -$6.02 |
Balance Sheet
The company has $53.17 million in cash and $37.87 million in debt, giving a net cash position of $15.30 million or $0.23 per share.
| Cash & Cash Equivalents | 53.17M |
| Total Debt | 37.87M |
| Net Cash | 15.30M |
| Net Cash Per Share | $0.23 |
| Equity / Book Value | 82.77M |
| Book Value Per Share | 1.24 |
| Working Capital | 27.11M |
Cash Flow
In the last 12 months, operating cash flow was -$120.90 million and capital expenditures -$1.36 million, giving a free cash flow of -$122.26 million.
| Operating Cash Flow | -120.90M |
| Capital Expenditures | -1.36M |
| Free Cash Flow | -122.26M |
| FCF Per Share | -$2.32 |
Margins
Gross margin is 27.54%, with operating and profit margins of -547.31% and -605.26%.
| Gross Margin | 27.54% |
| Operating Margin | -547.31% |
| Pretax Margin | -605.21% |
| Profit Margin | -605.26% |
| EBITDA Margin | -554.87% |
| EBIT Margin | -591.43% |
| FCF Margin | -326.28% |
Dividends & Yields
BNGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -74.60% |
| Shareholder Yield | -74.60% |
| Earnings Yield | -297.56% |
| FCF Yield | -160.41% |
Analyst Forecast
The average price target for BNGO is $4.00, which is 250.88% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.00 |
| Price Target Difference | 250.88% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 31.41% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 7, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Aug 7, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
BNGO has an Altman Z-Score of -9.01 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.01 |
| Piotroski F-Score | 4 |